ZNP-22480-31241
4 vaccinations
3 coded responses
30 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 150 / PA
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-22
- 2020-12-28
- 2021-01-03
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-18
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-15
- 2021-02-20
- 2021-04-10
- 2021-07-12
-
2021-10-14
Dose 3 — Pfizer-BioNTech
- 2022-01-09
-
2022-09-26
Dose 4 — Pfizer-BioNTech
- 2022-09-29
- 2022-10-03
- 2022-10-10
- 2022-10-17
-
2022-10-26
Survey response — day 28, dose 4MedDRA: Pre-eclampsia — Feeling: GoodFree text: Pre eclampsiaMedDRA releases: 2024-11 · check-in free text available
- 2022-10-31
- 2022-11-07
-
2022-12-26
Survey response — 3 months, dose 4MedDRA: Pre-eclampsia — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Pre eclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-12-26
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-12-28
-
2023-03-29
Survey response — 6 months, dose 4MedDRA: Hypertension, Pre-eclampsia — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-29
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-03-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-09-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-26 | Successful 2023-03-30 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-03-29 | Successful 2023-03-30 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 — day 28, dose 4
Symptoms: Pre eclampsia
Release 12 — 3 months, dose 4
Symptoms: Pre eclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypertension | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release